US cancer screenings slow to recover from initial pandemic dip

Early in COVID-19, rates of lung and breast cancer screenings among Medicare enrollees were 24% and 17%, respectively, below expected rates, rising to -14% and -4% later on.

Read the full article here

Related Articles